USP5 and rheumatoid arthritis: Glucose uptake and lactate production measurements revealed that TNF-α treatment significantly enhanced glycolysis in RA-FLSs, whereas USP5 knockdown or 2-DG treatment markedly reduced these glycolytic parameters (Fig. 2F).